Complexities of Cystic Fibrosis Pulmonary Care

Pharmacist CEU
Contact Hours: 1.0 (0.1 CEUs)

Course Summary

Cystic fibrosis (CF) is considered a rare disease, according to the National Organization of Rare Diseases, and is one of the most commonly diagnosed genetic disorders. Approximately 30,000 people are living with CF in the United States, with 1,000 new cases diagnosed every year. Pulmonary complications and clinical characteristics, including progressive obstructive lung disease, sinusitis, and infection, among others, contribute to significant morbidity. Although CF is a life-shortening disease, survival has improved due to earlier diagnosis through routine newborn screening, evidence-based guidelines to optimize pulmonary health, and the development of CF-specific interdisciplinary care centers. Pharmacists are well-positioned to engage in shared decision-making regarding treatments for CF pulmonary conditions and to remain aware of the comprehensive safety and efficacy of these treatments.

Course Objectives

Describe the common clinical pulmonary manifestations of cystic fibrosis (CF)

Identify laboratory and genetic studies needed to diagnose CF

Recognize the most common presentations of CF-related complications

Describe the current recommendations for long-term maintenance of optimal lung health in CF patients

I. Introduction

II. Epidemiology

III. Pathophysiology

IV. Clinical Presentation

V. Screening and Diagnosis

VI. Cystic Fibrosis Management

VII. Therapies to Maintain Lung Health

1. Clearance of Airway Secretions
2. Chronic Airway Infections

VIII. CFTR Modular Therapies

IX. Pulmonary and Extrapulmonary CF Complications

1. Pulmonary Exacerbation (PEx)
2. Hemoptysis
3. Pneumothorax
4. Chronic Rhinosinusitis (CRS) and Nasal Polyposis

X. Transitioning to Adulthood

XI. Patient Counseling

XII. Next Steps

XIII. Summary

How to Earn Credit:
To earn credit for this course, participants must:
  1. Read the course objectives and faculty planner disclosure
  2. Read the course material
  3. Complete the post-test with a minimum score of 70% and complete the course evaluation form.
  4. Results are automatically submitted to CPE Monitor

Faculty Planner Disclosure

The following individuals were involved in developing this activity: Pamela Sardo, PharmD, BS. Pamela Sardo was an employee of Rhythm Pharmaceuticals until March 2022 and has no conflicts of interest or relationships regarding the subject matter discussed. There are no financial relationships relevant to this activity to report or disclose by any of the individuals involved in the development of this activity.

Unlabeled Use Disclosures

The information provided in this course is general in nature and it is solely designed to provide participants with continuing education credit(s). This course and materials are not meant to substitute for the independent, professional judgment of any participant regarding that participant’s professional practice, including but not limited to patient assessment, diagnosis, treatment and/or health management. Medical and pharmacy practices, rules, and laws vary from state to state, and this course does not cover the laws of each state; therefore, participants must consult the laws of their state as they relate to their professional practice. Healthcare professionals, including pharmacists and pharmacy technicians, must consult with their employer, healthcare facility, hospital, or other organization, for guidelines, protocols, and procedures they are to follow. The information provided in this course does not replace those guidelines, protocols, and procedures but is for academic purposes only, and this course’s limited purpose is for the completion of continuing education credits. Participants are advised and acknowledge that information related to medications, their administration, dosing, contraindications, adverse reactions, interactions, warnings, precautions, or accepted uses are constantly changing, and any person taking this course understands that such person must make an independent review of medication information prior to any patient assessment, diagnosis, treatment and/or health management. Any discussion of off-label use of any medication, device, or procedure is informational only and such uses are not endorsed hereby. Nothing contained in this course represents the opinions, views, judgments, or conclusions of LLC. LLC is not liable or responsible to any person for any inaccuracy, error, or omission with respect to this course, or course material.

Computer Hardware/Software Requirements

Please ensure the device you plan to use meets these requirements and specifications:

  • Operating System: Windows 7,8,10, or 11 /Mac OS X 10.9 or later/iOS/Android
  • Supported Browsers: Microsoft Edge, Firefox, Google Chrome, Safari, Opera
  • A connection to the internet
  • For Live Webinars or Conferences: GoToWebinar application for iOS, Android, Mac, or PC. You cannot 'call into' a live conference.

  • Target Audience: Pharmacist
  • Contact Hours: 1.0 (0.1 CEUs)
  • Activity Release Date: 10/17/2023
  • Activity Expiration Date: 10/17/2026
  • Activity Type: Knowledge
  • UAN: 0669-0000-23-172-H01-P
  • Topic: Disease State Management/Drug Therapy
  • CeBroker Number: 20-1117190


Pamela Sardo, Pharm.D., B.S.



The logo for the Accreditation Council for Pharmacy Education (ACPE)., LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

‹‹ Back to Course List